Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Branched-chain amino acids.

C Platell1, S E Kong, R McCauley

  • 1University Department of Surgery at Fremantle Hospital, Perth, Western Australia, Australia.

Journal of Gastroenterology and Hepatology
|August 11, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemical, morphological, and genetic characterization of the floral scent and scent-releasing structures of Gynandropsis gynandra (Cleomaceae, Brassicales).

Plant biology (Stuttgart, Germany)·2025
Same author

On Opacities of the Cornea.

Western journal of medicine and surgery·2024
Same author

Case of Pelvic Tumour.

Medical examiner (Philadelphia, Pa.)·2023
Same author

Australasian ACPGBI risk prediction model for 30-day mortality after colorectal cancer surgery.

BJS open·2020
Same author

The Drosophila period Gene and Dye Coupling in Larval Salivary Glands: A Re-evaluation.

The Biological bulletin·2018
Same author

Exploration of information and support needs in relation to health concerns, diet and physical activity in colorectal cancer survivors.

European journal of cancer care·2017

Branched-chain amino acids (BCAA) show limited clinical benefit in liver failure and critical illness, despite improving protein synthesis. Further research into BCAA

Area of Science:

  • Biochemistry
  • Clinical Nutrition
  • Metabolic Research

Background:

  • Branched-chain amino acids (BCAA)—isoleucine, leucine, and valine—are primarily metabolized in skeletal muscle.
  • BCAA metabolism and potential clinical applications have been extensively investigated.
  • Previous studies focused on liver failure and catabolic disease states.

Purpose of the Study:

  • To evaluate the clinical efficacy of BCAA nutritional supplements.
  • To determine the impact of BCAA on patient outcomes in specific clinical scenarios.
  • To identify potential future research directions for BCAA supplementation.

Main Methods:

  • Review of clinical studies investigating BCAA supplementation.
  • Analysis of BCAA effects on nitrogen retention and protein synthesis.

Related Experiment Videos

  • Assessment of BCAA impact on survival and morbidity in critically ill patients.

    • Main Results:

    • BCAA supplementation improved nitrogen retention and protein synthesis in liver failure patients.
    • Clinical outcomes (patient survival, morbidity) were not clearly improved by BCAA.
    • BCAA did not enhance survival or reduce morbidity in critically ill septic patients.

    Conclusions:

    • Current evidence does not support a clear clinical benefit of BCAA supplements in liver failure or critical illness.
    • Understanding the underlying cellular biology of BCAA is crucial for identifying specific benefits.
    • Future research may explore combining BCAA with anabolic factors for catabolic conditions.